Roughly 1 in 350 men and 1 in 400 to 470 women will develop amyotrophic lateral sclerosis (ALS) over the course of a lifetime, depending on which population study you consult. That makes ALS far rarer than heart disease or most cancers, yet common enough that nearly everyone knows someone, or knows of someone, affected by it. The numbers themselves, though, hide a lot of complexity beneath them, because ALS risk is not evenly distributed across age, sex, genetics, or geography.
Lifetime Risk in Numbers
Two large population-based studies provide the most commonly cited lifetime risk estimates. A UK study found that, after adjusting for competing causes of death, roughly 1 in 350 men and 1 in 472 women will develop ALS at some point during their lives.1PubMed Central. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study A Dutch study using twin registry data arrived at similar figures: about 1 in 347 men and 1 in 436 women.2JAMA Neurology. Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis Both studies agree that the risk over a full lifespan lands somewhere around 1 in 300 to 1 in 500, with men consistently facing higher odds.
An important nuance in the Dutch study is the difference between the “current” lifetime risk and the risk that applies to a given generation. When the researchers adjusted for the fact that average life expectancy changes over time, the lifetime risk dropped: about 1 in 550 for men and 1 in 670 for women based on each person’s actual expected lifespan, and even lower when calculated using their parents’ life expectancy.2JAMA Neurology. Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis The takeaway is that how long a population tends to live matters for these estimates. As lifespans lengthen, more people reach the ages at which ALS typically strikes, and projected global prevalence is expected to rise in the coming decades partly for that reason.3Annals of Clinical and Translational Neurology. Study Forecasts Uptick in ALS Prevalence in Coming Decades
Why Men Get ALS More Often Than Women
Across nearly every study, men are diagnosed with ALS more frequently than women. The male-to-female ratio is typically around 1.3 to 1.5 to 1, meaning men face roughly 30 to 50 percent higher odds. But this gap is not constant across the lifespan. Data from a population-based registry showed that the male-to-female ratio was above 2.5 in younger age groups and fell below 1.5 after menopause, with the proportion of women among cases rising from about 30 percent in pre-menopausal ages to around 44 percent afterward.4PubMed Central. The sex ratio in amyotrophic lateral sclerosis: A population based study That pattern has led researchers to suspect that estrogen or related hormonal factors provide some degree of protection, which weakens after menopause. The evidence is still circumstantial, but the sharp convergence in risk around menopause is one of the more consistent epidemiological findings in ALS research.
Age and Peak Risk
ALS is primarily a disease of middle and later life. Incidence rises sharply after age 40, peaks somewhere between the mid-60s and mid-70s depending on the population studied, and then declines in the oldest age groups. A diagnosis before age 40 is unusual, and onset before 25 is extremely rare, sometimes called juvenile ALS, which is almost always linked to specific genetic mutations. ALS is typically fatal within two to five years of symptom onset, though survival varies widely.5PubMed Central. Risk factors for amyotrophic lateral sclerosis Younger age at onset is generally associated with slower progression. Where symptoms begin also matters: people whose first symptoms affect speech and swallowing tend to have shorter survival than those whose symptoms begin in the legs, partly because of the higher risk of respiratory complications.6Journal of Neurology, Neurosurgery & Psychiatry. A clinical tool for predicting survival in ALS A recent study confirmed that lower-limb onset was associated with slower decline on standard functional measures compared to both upper-limb and bulbar (speech/swallowing) onset.7PubMed Central. Slower Progression Rates in Lower Limb-Onset ALS
The Genetics Question
About 5 to 10 percent of ALS cases are classified as “familial,” meaning the person has a known family history of the disease. The rest are called “sporadic,” which essentially means no obvious inherited pattern. A meta-analysis pooling over 160 studies found that the overall proportion classified as familial was about 8 percent, though estimates from rigorous population-based studies settled closer to 5 percent.8PubMed Central. Estimated Familial Amyotrophic Lateral Sclerosis Proportion: A Literature Review and Meta-Analysis The distinction between familial and sporadic is a bit misleading, though. Many “sporadic” cases carry genetic risk variants, and the line between the two categories has blurred as genetic testing has expanded.
The most commonly identified genetic culprit is a repeat expansion in the C9orf72 gene, which accounts for a large share of familial cases and a smaller but meaningful share of sporadic ones. Over half of patients with C9orf72 mutations in one large study had no family history of ALS at all.9Brain Communications. Clinical and genetic features of amyotrophic lateral sclerosis patients with C9orf72 mutations The penetrance of C9orf72 is incomplete and age-dependent, meaning carrying the mutation does not guarantee you will develop ALS, and the risk increases the older you get.10PubMed Central. Age-related penetrance of the C9orf72 repeat expansion Mutations in the SOD1 gene are the second most studied, and they behave quite differently: some SOD1 variants are associated with very aggressive disease, while others follow a much slower course spanning a decade or more.11PubMed. Clinical trajectories and genetic profiles of SOD1-related amyotrophic lateral sclerosis: insights from a single-center cohort in India
If a close relative has ALS, your own risk is meaningfully elevated compared to the general population, but it is far from a certainty. Most children of a parent with familial ALS will not develop the disease, though genetic counseling is available and increasingly recommended for families with a known mutation.
ALS as a Multistep Process
One influential model describes ALS as requiring roughly six distinct biological “steps” before the disease manifests. This idea comes from analyzing how incidence rates change with age, and the pattern closely matches what would be expected if multiple independent events must accumulate before disease onset.12PubMed Central. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study People carrying a major genetic mutation like C9orf72 appear to start with some of those steps already completed. When researchers applied the same analysis to C9orf72 carriers, the data fit a three-step model instead of a six-step one, suggesting the mutation effectively accounts for about half the required hits.13PubMed Central. The multistep hypothesis of ALS revisited: The role of genetic mutations
This framework matters because it explains why even people with strong genetic predispositions often never get sick. If you need six steps and a mutation provides two or three of them, you still need the remaining steps from environmental exposures, aging, or plain bad luck. It also helps explain why no single environmental risk factor has a large enough effect to account for most cases on its own.
Environmental and Lifestyle Factors
Because most ALS cases are sporadic, researchers have spent decades searching for environmental contributors. The evidence is strongest for a few broad categories, though none is powerful enough to be considered a primary cause.
Smoking is probably the best-established modifiable risk factor. A pooled analysis of five large prospective studies found that people who had ever smoked faced roughly 40 percent higher ALS risk compared to never-smokers.14PubMed Central. Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of five prospective cohorts A more recent meta-analysis including a wider range of study designs arrived at a somewhat smaller estimate, about 12 to 14 percent increased overall risk, with the association strongest among current smokers (about 28 percent increased risk).15Tobacco Induced Diseases. Association of smoking with amyotrophic lateral sclerosis: A systematic review, and meta-analysis, including dose-response analysis The difference between those estimates reflects different study pools and methods, but the direction of the finding is consistent: smoking raises ALS risk by a moderate amount.
Head injuries have also drawn attention, especially after public concern about ALS in contact-sport athletes. A study combining original case-control data with a meta-analysis found that a single head injury was associated with a modest increase in risk, but multiple head injuries were tied to roughly a threefold increase, and the combination of repeated head injuries and recent occurrence raised risk more than elevenfold.16PubMed Central. Head injury and amyotrophic lateral sclerosis A large 2025 cohort study added an interesting wrinkle: ALS risk was sharply elevated in the two years following a traumatic brain injury but did not persist beyond that window, raising the possibility that some of the association reflects early ALS symptoms causing falls rather than injury causing ALS.17JAMA Network Open. Traumatic Brain Injury and Risk of Amyotrophic Lateral Sclerosis This kind of reverse causation is a persistent challenge in ALS epidemiology.
Occupational pesticide exposure carries a fairly robust signal. A recent meta-analysis found that people with occupational pesticide exposure had about 60 percent higher ALS risk, and those with high-level exposure faced a roughly 2.7-fold increase.18PubMed Central. Occupational exposure to pesticides increases the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis Herbicides appeared slightly riskier than insecticides or fungicides, though the differences were small.
Military service has been identified as a risk factor in multiple studies. Two separate meta-analyses both arrived at a pooled odds ratio of about 1.29, meaning roughly 30 percent higher risk among those who served compared to the general population.19PubMed Central. Military service and related risk factors for amyotrophic lateral sclerosis Whether this reflects chemical exposures, physical trauma, strenuous activity, or something else entirely remains unknown.
The Complicated Story of Physical Activity
For years, ALS was informally called “the athlete’s disease” because of clusters in professional athletes and an impression that very fit people seemed disproportionately affected. The actual evidence is more muddled than that reputation suggests. A review of the literature concluded that strenuous physical activity over a lifetime probably does increase ALS risk, but mainly when a genetic susceptibility is already present.20PubMed Central. Physical activity as an exogenous risk factor for amyotrophic lateral sclerosis: a review of the evidence In other words, intense exercise may be one of the “steps” in the multistep model for people who are already partway there genetically.
Yet a large prospective cohort study from Scandinavia found the opposite pattern in the general population: men who reported the highest levels of physical activity had roughly 30 to 40 percent lower ALS risk compared to the least active men. In women, no clear relationship was detected either way.21PubMed. Physical Activity, Fitness, and Long-Term Risk of Amyotrophic Lateral Sclerosis: A Prospective Cohort Study These contradictory findings probably reflect different things being measured. Moderate regular activity in the general population is not the same as decades of elite-level training, and genetic background likely determines which direction the effect goes.
Body Weight and ALS Risk
An unexpected finding from several large studies is that people with higher body mass tend to have lower ALS risk. A pooled analysis of five prospective cohorts found that for every five-unit increase in BMI, ALS risk dropped by about 21 percent, with overweight and obese individuals at roughly 25 to 27 percent lower risk compared to those at a normal weight.22PubMed Central. Premorbid Body Mass Index and Risk of Amyotrophic Lateral Sclerosis This is a pre-disease association, meaning it reflects body weight measured years before any ALS symptoms appeared.
However, a Mendelian randomization study, which uses genetic variants linked to BMI as a proxy for a natural experiment, found no causal relationship between BMI and ALS risk in either European or East Asian populations.23PubMed Central. Association Between Premorbid Body Mass Index and Amyotrophic Lateral Sclerosis: Causal Inference Through Genetic Approaches That suggests the observational association may not be straightforward cause-and-effect. One possibility is that the metabolic changes of very early, undiagnosed ALS drive weight loss years before the disease is formally recognized. Another is that shared genetic factors influence both body weight and ALS susceptibility without one actually causing the other.
Racial and Ethnic Differences
ALS is not equally common in all populations. Within the United States, white (non-Hispanic) populations have consistently shown the highest incidence. African American, Asian, and Hispanic populations all have lower rates.24PubMed Central. Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States Globally, a systematic review found wide variation, with incidence ranging from as low as 0.26 per 100,000 person-years in Ecuador to 23.46 per 100,000 in Japan.25PubMed Central. Global Prevalence and Incidence of Amyotrophic Lateral Sclerosis: A Systematic Review Part of this variation is real biological and genetic difference, but part of it almost certainly reflects differences in healthcare access, diagnostic capacity, and case ascertainment. In countries where neurology services are sparse, many cases are simply never counted.
A systematic review found consistently lower incidence in Asian populations compared to white (Caucasian) populations, even after controlling for age.26PubMed. Ethnic variation in the incidence of ALS: a systematic review Whether this reflects differences in genetic susceptibility, environmental exposures, or both remains an active research question.
Geographic Hot Spots
A handful of geographic clusters have been documented where ALS rates were dramatically higher than the global average. The most famous is the island of Guam, where in the mid-twentieth century, the Chamorro population experienced extraordinarily high rates of ALS-parkinsonism-dementia complex (ALS-PDC), a combined condition involving motor neuron disease alongside features of Parkinson’s and dementia.27PubMed Central. Guam ALS-PDC is a distinct double-prion disorder featuring both tau and Aβ prions A similar cluster was documented on the Kii peninsula of Japan.28PubMed Central. Tau filaments from amyotrophic lateral sclerosis/parkinsonism-dementia complex adopt the CTE fold
For decades, one leading hypothesis blamed BMAA, a neurotoxin produced by cyanobacteria (blue-green algae) that is found in cycad seeds traditionally consumed on Guam. Research on cyanobacterial blooms in freshwater lakes in the United States has also found a positive association between algal toxin exposure and regional ALS rates.29PubMed Central. Assessing Cyanobacterial Harmful Algal Blooms as Risk Factors for Amyotrophic Lateral Sclerosis However, animal studies using chronic low-dose BMAA exposure have so far failed to produce the expected neurodegenerative symptoms, even in genetically susceptible animals.30PubMed Central. The Effects of Long-term, Low-dose β-N-methylamino-l-alanine (BMAA) Exposures in Adult SODG93R Transgenic Zebrafish The Guam cluster has largely faded over the decades as traditional diets have changed, which is both consistent with an environmental cause and frustrating for researchers trying to pin down exactly what it was.
Getting to a Diagnosis
One reason ALS statistics can feel unreliable is the difficulty of diagnosing it. There is no single blood test or scan that confirms ALS. The diagnosis is clinical, meaning doctors piece it together from the pattern of symptoms, physical exam findings, and a process of ruling out other conditions. About half of patients receive at least one wrong diagnosis along the way, and the average person sees three different doctors before ALS is confirmed.31PubMed Central. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)
The misdiagnosis pattern depends on where symptoms begin. When ALS starts with speech or swallowing problems, it is commonly mistaken for stroke, myasthenia gravis, or an ear-nose-and-throat condition. When it starts in the limbs, the usual dead ends include spinal disc disease, peripheral neuropathy, and orthopedic problems.32PubMed Central. Diagnostic Delay in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis Comparing Time From Symptom Onset to Diagnosis in Bulbar-Onset Versus Limb-Onset Disease These detours mean that months or even years can pass between the first symptoms and an ALS diagnosis. That delay matters because it compresses the window for treatment planning, clinical trial enrollment, and personal decision-making.
Can You Lower Your Risk?
Given that most ALS cases are sporadic and the multistep model suggests multiple independent events are needed, there is no proven way to prevent the disease. That said, a few of the modifiable risk factors discussed above point in directions that are good for your health regardless. Not smoking eliminates the most consistently supported environmental risk factor. Minimizing unprotected exposure to pesticides and other neurotoxic chemicals is prudent, especially for people in agricultural or industrial occupations. Protecting your head from repeated injury makes sense for many neurological reasons beyond ALS.
The physical activity question does not lend itself to clean advice. There is no evidence that ordinary recreational exercise raises ALS risk, and the prospective data suggest it may even be protective for most people. The potential concern is limited to extremely intense, sustained athletic training in people who may carry unknown genetic susceptibility, and even there the evidence is far from settled. Avoiding exercise in hopes of preventing ALS would be misguided.
For people with a family history of ALS, genetic counseling and testing are increasingly accessible. Knowing whether you carry a mutation like C9orf72 or SOD1 does not change the fact that penetrance is incomplete, so a positive result does not mean ALS is inevitable. But it does open the door to monitoring, future gene-targeted therapies, and informed reproductive planning. The first antisense oligonucleotide therapy specifically targeting SOD1 mutations received approval in 2023, which makes genetic knowledge actionable in a way it was not even a few years ago.